人体工学植入物隆乳术后下极扩张的结果分析与评估:基于5年数据的患者选择优化效果
研究纳入148例(296侧)接受人体工学植入物隆乳的患者,适应者为皮肤质量好且乳头乳晕复合体至乳房下皱襞距离小于6 cm者。平均随访29.9±26.4个月,下极扩张在术后10天内平均为32.2%(24.91 mm),10天至12个月平均为10.86%(9.42 mm),每侧和每例并发症率分别为5%和10%。作者提出决策算法以标准化决策,正确规划下可获得持久效果。
要点
- 适应者为皮肤质量好且乳头乳晕复合体至乳房下皱襞距离小于6 cm的患者。
- 术后10天内下极扩张平均32.2%(24.91 mm),10天至12个月平均10.86%(9.42 mm)。
- 每侧和每例并发症率分别为5%和10%,无感染、血清肿或波纹并发症。
核心结论
- 作者提出的决策算法总结了使用人体工学植入物隆乳的决策过程,旨在帮助标准化决策;正确规划下,由于植入物与患者组织间良好的相互作用,可获得持久效果。
研究设计与样本
- 本研究为针对148例患者(296侧乳房)接受人体工学植入物隆乳术后的结果分析,适应者为皮肤质量好且乳头乳晕复合体至乳房下皱襞距离小于6 cm者。
主要发现
- 患者平均年龄29.6岁(范围19-39岁),93例(62.8%)接受初次隆乳并使用半/全凸度假体(平均体积245 cc [175-375 cc])。
- 腋窝切口和筋膜下腔隙分别用于115例(77.7%)和72例(48%)。
- 术后10天内下极扩张平均值为32.2%(24.91 mm),术后10天至12个月平均值为10.86%(9.42 mm)。
- 患者平均随访29.9±26.4个月(范围6-66个月)。
- 每侧乳房和每例患者的并发症率分别为5%和10%,包括腋窝皮下条索(1.6%)、植入物移位(1.2%)和伤口裂开(0.8%);未观察到感染、血清肿或波纹并发症。
临床怎么用
- 作者提出的决策算法旨在帮助标准化使用人体工学植入物隆乳的决策过程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Silicone implants have gone through adaptations to improve esthetic outcomes. With the progress of technology, including gel rheology, different properties have been introduced. Ergonomic style implants (ESI) feature enhanced rheological properties and provide a shaped contour with a round base. OBJECTIVES: This study investigated outcomes for ESI in breast augmentation concerning lower pole stretching (LPS) and implant stability and describes an algorithm to assist in decision-making. METHODS: A total of 148 patients (296 breasts) underwent breast augmentation with ESI; this procedure was indicated in patients with good skin quality and <6 cm between the nipple-areola complex and the inframammary fold. RESULTS: The mean patient age was 29.6 years (range: 19-39), and 93 patients (62.8%) underwent primary breast augmentation with demi/full projection (average volume of 245 cc [175-375 cc]). Axillary incision and subfascial pocket were indicated in 115 (77.7%) and 72 (48%) cases, respectively. Average LPS values were 32.2% (24.91 mm) and 10.86% (9.42 mm) at up to 10 days and 10 days to 12 months postprocedure, respectively. Patients were followed for a mean of 29.9 ± 26.4 months (range: 6-66). Complication rates per breast and per patient were 5% and 10%, respectively, and included subcutaneous banding in the axilla (1.6%), implant displacement (1.2%), and wound dehiscence (0.8%). No cases of infection, seroma, or rippling complications were observed. CONCLUSIONS: The present decision-making algorithm summarizes the process involved in breast augmentation using ESI and is intended to help standardize decisions. With correct planning, long-lasting outcomes can be achieved due to favorable interactions between ESI and the patient's tissues.
引用
- Munhoz AM, Marques Neto AA, Maximiliano J, et al. Outcome analysis and assessment of the lower pole expansion following breast augmentation with ergonomic implants: Optimizing results with patient selection based on 5-year data. J Plast Reconstr Aesthet Surg. 2023. PMID: 37956630. doi:10.1016/j.bjps.2023.10.105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。